A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model. Purves K, Haverty R, O'Neill T, Folan D, et al. J Gen Virol 2023;104.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Purves K, Haverty R, O'Neill T, Folan D, et al. A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model. J Gen Virol 2023;104.
PMID: 36787173